Consultant Cardiologist | Heart Center 🇩🇪 @UniklinikBonn | Clinician Scientist | Project Leader @trr259 | Editorial Board Member @BMC_series

University Hospital Bonn
Our latest publication @JAHA_AHA investigating the prevalence, impact & strategies for severe multiple valvular heart disease #MVHD in #TAVR: Severe #MR & #TR were prevalent & associated with incr. mortality. Staged #TEER reduced 1- & 5-year mortality ➡️bit.ly/4jH2S0p
1
6
1,464
Our latest publication @ejhg_journal on the #genetic architecture of #bicuspid aortic valve (#BAV): Only ~2% of sporadic #BAV patients carry predicted deleterious rare variants in monogenic #BAV genes, suggesting that most #BAV cases are polygenic. bit.ly/4nV9iwB
1
2
10
467
Baravan Al-Kassou | MD retweeted
先日のパリ学会中でのインタビュー JACC cardio. Intervention に掲載された論文の事なんですが、 実は学会で場所が無く、静かな場所を求めて、急遽知人のホテルに転がり込ませてもらって収録した一本
What are the outcomes of #T_TEER in patients with #primary_TR? Check out this interview with @AtsushiSssugi discussing their #JACCINT manuscript jacc.org/doi/10.1016/j.jcin.… #CardioX #ACCFIT
2
29
3,855
Baravan Al-Kassou | MD retweeted
Severe multiple valvular heart disease increases mortality after #TAVR, with tricuspid regurgitation posing the highest risk. Read how staged transcatheter edge‐to‐edge repair improves outcomes. #AHAJournals @bara_doc @UniklinikBonn ahajrnls.org/44ohgX1
2
6
1,435
Baravan Al-Kassou | MD retweeted
🎙️NEW #CRT2025 Interview 💫@bara_doc discusses insights from the GUARD study on the progression and outcomes of mild to moderate #aortic #stenosis. 📽️Watch here👉 ow.ly/qKqK50VfTz9 #CardioEd #CardioTwitter
3
7
826
Fantastic keynote at #CRT2025 by @GeoffMartha, Chairman & CEO of #Medtronic, on the challenges & opportunities for Health Tech companies in this uncertain time of change. Even on the last day, the main arena is packed with engaged & motivated attendees. @CRT_meeting @Medtronic
1
7
424
Prof @ronwaksman expressing heartfelt gratitude to the incredible @CRT_meeting organizing team, who received well-deserved applause from attendees! A fantastic meeting and an unforgettable experience—thank you for making #CRT2024 a success! 👏🏼 #CRTTeam
1
6
380
Honored to receive a Young Leadership invitation to attend the CRT Meeting 2025. Grateful for this opportunity and excited to engage with fellow leaders and experts at this prestigious event. Looking forward to insightful discussions and learning ahead! @CRT_meeting #CRT2025
1
4
26
1,290
Baravan Al-Kassou | MD retweeted
In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years. Full trial results and Research Summary: nej.md/4i2U6dV
40
112
18,351
Baravan Al-Kassou | MD retweeted
Ihr forscht zum Thema interventionelle Kardiologie? ⬇️EURE CHANCE ⬇️ Noch bis morgen Euer Projekt für den Andreas-Grüntzig-Forschungspreis einreichen ✊ Alle Infos: herzmedizin.de/fuer-aerzte-u… @AGIKinterv @YoungDgk @DGK_org @Kardiophil @TSchneiderMD @KardiologieHH @bara_doc
5
18
2,877
SGLT2i can reduce the incidence of new-onset diabetes among individuals with cardiovascular or kidney disease. Read more in #EHJ 👉 bit.ly/4eMWqTe @RoccoMontone @ehj_ed #diabetes
1
50
163
17,216
Baravan Al-Kassou | MD retweeted
A tale of measured and predicted prosthesis-patient-mismatch #PPM after #TAVR - an analysis of the #IMPPACT TAVI registry by @HenningGuthoff just published in @JACCJournals #JACCInt, accompanied by an editorial of the godfather of PPM @PPibarot bit.ly/3V93T8p 🧵(1/8)
3
10
25
4,194
Baravan Al-Kassou | MD retweeted
Presented at #AHA24: Among patients with ventricular tachycardia and ischemic cardiomyopathy, catheter ablation as an initial therapy led to a lower risk of adverse outcomes than antiarrhythmic drug therapy. Read the full VANISH2 trial results: nej.md/3Z5ECOD
3
121
275
45,433
Our latest publication @JAMACardio: We identified 17 #AorticStenosis specific genetic loci, including 5 novel loci. Serum #phosphate is a unique AS risk factor. Our findings reveal AS's distinct pathways from #CAD, paving the way for targeted therapies. ➡️bit.ly/4ezb2pq
6
26
1,995
Baravan Al-Kassou | MD retweeted
BREAKING NEWS The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
545
11,160
27,276
4,702,428
Baravan Al-Kassou | MD retweeted
Hospitation im Hybrid-Op bei einer #TAVI? 🤩🫀 Von Zugangsweg über Prothesenpräparation bis hin zum Verschlusssystem 👀 Alles eine Frage des #Teamwork 🤝 Hier gibt es das ganze Video: piped.video/Vtb9CuOY1CA?si=Cz_V… @AtsushiSssugi @bara_doc @MAlZaidi_ @AndreasZietzer @HubrichtD
2
20
4,391
Baravan Al-Kassou | MD retweeted
Among various #myocarditis diagnostic criteria, ESC criteria for clinically suspected myocarditis and updated Lake Louise criteria had the highest prognostic value. bit.ly/4eKsVSl #JACC @chrisgraeni
5
65
188
23,290
Spannende Session auf den #DGKHerztage|n zur #TAVI Nachsorge – von paravalvulärer Insuffizienz bis hin zu Schrittmacherstrategien und Endokarditis nach TAVI. 💡 Wertvolle Einblicke von Top-Experten! @AGIKinterv @DGK_org @EPTIG @KardiologieHH
3
14
682
Toller Vortrag 🔥 mit hilfreichen Einblicken und praktischen Tipps von @ElenaRepges am @YoungDgk Stand über die Strukturierung eines Abstracts! Großer Andrang und großes Interesse der Anwesenden. #DGKHerztage @DGK_org
1
4
19
788
Baravan Al-Kassou | MD retweeted
Der zweite Showtag @DGK_org kann beginnen! Auf dem Programm stehen 1️⃣6️⃣ spannende @AGIKinterv Sessions: 🔥 4️⃣ Workshops 📍Saal C 🔥 2️⃣ Sessions speziell für Assistenzpersonal 📍Saal X1 🔥 3️⃣ AGIK Cinema-Sessions📍Saal X3 🔥 7️⃣ interessante Sessions 📍Saal G1 und Saal 3
6
11
671